Mitochondria are physically and biochemically in contact with other organelles including the endoplasmic reticulum (ER). Such contacts are formed between mitochondria-associated ER membranes (MAM), specialized subregions of ER, and the outer mitochondrial membrane (OMM). We have previously shown increased expression of MAM-associated proteins and enhanced ER to mitochondria Ca 2+ transfer from ER to mitochondria in Alzheimer's disease (AD) and amyloid b-peptide (Ab)-related neuronal models. Here, we report that siRNA knockdown of mitofusin-2 (Mfn2), a protein that is involved in the tethering of ER and mitochondria, leads to increased contact between the two organelles. Cells depleted in Mfn2 showed increased Ca 2+ transfer from ER to mitchondria and longer stretches of ER forming contacts with OMM. Interestingly, increased contact resulted in decreased concentrations of intra-and extracellular Ab 40 and Ab 42 . Analysis of c-secretase protein expression, maturation and activity revealed that the low Ab concentrations were a result of impaired c-secretase complex function. Amyloid-b precursor protein (APP), b-site APP-cleaving enzyme 1 and neprilysin expression as well as neprilysin activity were not affected by Mfn2 siRNA treatment. In summary, our data shows that modulation of ER-mitochondria contact affects c-secretase activity and Ab generation. Increased ER-mitochondria contact results in lower c-secretase activity suggesting a new mechanism by which Ab generation can be controlled.
Introduction
Organelles are dynamic and in contact with each other. One example is the endoplasmic reticulum (ER) that is physically and biochemically connected with the outer membrane of mitochondria (OMM). These connections occur at subregions of the ER membrane referred to as mitochondria-associated ER membranes (MAM). Mitochondria-associated ER membranes are specialized cholesterol-rich stretches of ER membranes with similar properties and composition as lipid rafts [1] . The distance between ER and OMM at the contacts is approximately 20-30 nm [2] . Several proteins have been described to tether ER and mitochondria in mammalian cells. Such proteins include: mitofusin-2 (Mfn2), phosphofurin acidic cluster sorting protein-2, inositol 1,4,5-triphosphate receptor 3 (IP3R3), glucose-regulated protein and voltagedependent anion channel 1 (VDAC1) [3] [4] [5] [6] . Mitofusin-2 is located both in MAM and OMM, while Mfn1 is restricted to the OMM [6] . Previous studies have suggested that mitofusin homo-and heterodimers (Mfn2-Mfn2 and Mfn2-Mfn1) form an ER-mitochondria tethering complex. However, recent data propose that Mfn2 instead acts as a negative regulator, preventing excess of contacts between the two organelles [7] [8] [9] . These studies show that reduction of Mfn2 in mouse embryonic fibroblasts results in increased ER-mitochondria coupling and Ca 2+ transfer [7, 8] . Ca 2+ is released at MAM via the IP3Rs and taken up by mitochondria via VDAC1 (in the OMM) and the mitochondrial Ca 2+ uniporter (MCU, in the inner mitochondrial membrane) [3, [10] [11] [12] . Moreover, it has been shown that ER-mitochondria tethering and the Ca 2+ transfer between the two organelles are enhanced in cells expressing a familial Alzheimer's disease mutation in presenilin-2 (PS2) [13] .
Other functions of MAM and ER-mitochondria communication include: phospholipid and cholesterol synthesis and trafficking, formation of autophagosomal membranes and regulation of apoptosis [14] [15] [16] . Interestingly, all these processes are affected in Alzheimer's disease (AD) pathogenesis [1, 10, [17] [18] [19] [20] [21] [22] [23] . We have previously reported that the expression of MAM-associated proteins is up-regulated in AD postmortem tissues and that primary neurons exposed to Ab show an increased number of ER-mitochondria contacts as detected by the proximity ligation assay [24] . Other studies show that the synthesis of cholesteryl esters and phospholipids is increased in fibroblasts derived from AD patients and in cells treated with apolipoprotein e4-conditioned medium [14, 25] .
Alzheimer's disease is a multifactorial neurodegenerative disease characterized by several neurological impairments. Pathological hallmarks include accumulation of extracellular amyloid plaques and intraneuronal fibrillary tangles [26] [27] [28] . The amyloid b-peptide (Ab) is the main component of amyloid plaques. Ab is generated via proteolytic processing of the amyloid-b precursor protein (APP) by two enzymes: b-site APP-cleaving enzyme 1 (BACE1) and the c-secretase complex. The c-secretase complex consists of four different proteins: Nicastrin (NCT), presenilin enhancer 2 (PEN-2), anterior pharynx-defective 1 (APH-1) and PS1 or PS2 [29] [30] [31] [32] . In the amyloidogenic pathway, APP is first cleaved by BACE1 generating sAPPb and C99. C99 is subsequently cleaved by c-secretase to generate Ab and APP intracellular domain (AICD) [29] [30] [31] [32] . In the non-amyloidogenic pathway APP is first cleaved by a-secretase which generates sAPPa and C83. The C83 fragment is subsequently cleaved by c-secretase generating a p3 fragment and AICD.
Several studies have shown enrichment of APP, PS1/PS2, Ab as well as c-secretase activity in lipid rafts and MAM [14, 33, 34] . Accordingly, we recently demonstrated that significant amounts of Ab 40 and Ab 42 are generated from MAM-enriched subcellular fractions of mouse brain [34] . Thus, a fraction of Ab is generated in the vicinity of mitochondria, where it could exert a toxic effect.
Here, we have investigated the role of ER-mitochondria interplay in the regulation of Ab production. Our data show that siRNA knockdown of Mfn2 results in increased contact between the two organelles leading to increased Ca 2+ transfer from ER to mitochondria and decreased Ab concentrations. Interestingly, c-secretase complex maturation and activity is impaired in these conditions revealing a new mechanism by which cells regulate Ab production.
Material and methods
Additional details are given in Data S1.
Cell viability and ATP levels
Cell viability was measured using the dye alamarBlue â (#DAL1025; Thermo Fisher Scientific, Waltham, MA, USA) and Mitochondrial ToxGlo TM (#G800; Promega , Madison, WI, USA). In the first assay, cells were incubated with 19 AlamarBlue â solution for 30 min. at 37°C, and part of the sample media was removed and fluorescence (k ex = 530-560 nm, k em = 580-610 nm) was measured. With Mitochondrial ToxGlo TM both cell viability and ATP levels were measured according to the manufacturer's protocol.
Transmission electron microscopy
Cells were pelleted and fixed in 2.5% (vol/vol) glutaraldehyde in 0.1 M phosphate buffer at room temperature, rinsed in 0.1 M phosphate buffer, post-fixed in 2% OsO 4 for 2 hrs, dehydrated in ethanol and acetone and finally embedded in LX-112 (Ladd, Burlington, VT, USA). Ultrathin sections were prepared using Leica Ultracut UCT (Leica, Wien, Austria) and contrasted with uranyl acetate followed by lead citrate. Specimens were examined in a Tecnai 12 BioTWIN transmission electron microscope (FEI Company, Eindhoven, The Netherlands) at 100 kV. Digital images were taken with a Veleta camera (Olympus Soft Imaging Solutions, GmbH, M€ unster, Germany) at a primary magnification of 20,5009. Pictures were then analysed using Image J software (National Institutes of Health, Bethesda, MD, USA).
Aequorin Ca 2+ measurements
Aequorin measurements were performed as previously described [13] and are summarized in Data S1.
Determination of intra-and extracellular Ab 40 and Ab 42 concentrations 
c-secretase activity assay
All procedures were performed on ice or at 4°C. First, cells were harvested and spun down at 1500 9 g, for 5 min. The supernatant was removed and pellet resuspended in buffer H [20 mM HEPES, 150 mM NaCl, 2 mM ethylenediaminetetraacetic acid (EDTA)]. Cells were then lysed by using G27 needles (Misawa) (130 strokes) and centrifuged at 1000 9 g for 15 min. The pellet (nuclei fraction) was discarded while the supernatant (membrane fraction) was centrifuged at 100,000 9 g for 1 hr. Pellet was then solubilized in buffer H containing 1% CHAPSO. Samples were shaken for 1 hr, and centrifuged again at 10,000 9 g for 5 min. to remove insolubilized membranes. 
Statistical analysis
All data were analysed using IBM SPSS Statistics 22 software (IMB Corporation, New York, NY, USA). Data were evaluated for normal distribution using Kolmogorov-Sminorv test, checking the skewness of the distribution and Q-Q plot. Normally distributed data were compared by two-tailed independent-samples t-test. Not normally distributed data were compared by non-parametric, independent Mann-Whitney U-test. All values are expressed as mean AE S.E.M., n corresponds to number of independent experiments, *P < 0.05 and **P < 0.001 were considered to be significant.
Results
Cell viability and ATP levels are maintained during Mfn2 knockdown HEK293 cells stably overexpressing APP Swedish mutation (HEK293 APPswe) were used as a model system. The Swedish double mutation (KM670/671NL), located close to the BACE1 cleavage site on APP, enhances generation of the c-secretase substrate C99 and consequently Ab [35] [36] [37] [38] . Overexpression of APPswe in HEK293 cells was confirmed by Western blot (Fig. 1A ). The expression of Mfn2 and mitochondrial marker translocase of the inner membrane subunit 23 (TIM23) was not affected by the APPswe overexpression (Fig. 1A ).
To modulate ER-mitochondria contacts, cells were treated with Mfn2 siRNA or negative control (NC) siRNA for 48 hrs (Fig. 1B) . Downregulation of Mfn2 was accompanied by a slight increase in Mfn1 expression, while TIM23 expression was not affected (Fig. 1B) . The effect of Mfn2 knockdown on cell viability and energy production was investigated using the alamarBlue â and Mitochondrial ToxGlo TM assays. No differences in cell viability (reducing power and plasma membrane permeability) and ATP levels were detected between NC-and Mfn2 siRNA-treated cells ( Fig. 1C and D) . Analysis of cell morphology in a bright field microscope revealed that cells maintained their morphology during the treatment with Mfn2 siRNA (data not shown).
Knockdown of Mfn2 leads to extended ERmitochondria contact length and increased Ca

2+ transfer between the two organelles
The impact of Mfn2 knockdown on ER-mitochondria juxtaposition was analysed by transmission electron microscopy (TEM; Fig. 2A ). In the analysis, ER-mitochondria contact was considered to be formed when the distance between the two membranes was ≤ 30 nm [2] . Mitofusin-2 knockdown increased the length of the ER stretches in contact with mitochondria, as compared to control ( Fig. 2A and B) . Accordingly, the percentage of the mitochondrial surface in contact with the ER increased in Mfn2 siRNA-treated cells, as compared to control (Fig. 2C) . The number of ER-mitochondria contacts and mitochondria, and the mitochondria perimeter, were unaltered by Mfn2 siRNA (Fig. S1A and B) . Mitochondrial morphology was affected, as shown by dilation of mitochondrial cristae in Mfn2 siRNA-treated cells ( Fig. 2A) .
To elucidate whether the increased physical coupling between the two organelles had a functional impact, we analysed the Ca 2+ transfer from ER to mitochondria. An increased juxtaposition between the two organelles favours the shuttling of Ca 2+ , while a decreased juxtaposition decreases the Ca 2+ shuttling [39, 40] . To test the efficiency of Ca 2+ transfer, HEK293 APPswe cells were cotransfected with cDNA encoding for the mitochondrial matrix-targeted Ca 2+ probe, aequorin, and the Mfn2 (or NC) siRNA. After 48 hrs, cells were stimulated with ATP and carbachol (CCH) to induce an IP3-dependent ER Ca 2+ release. A significant increase in mitochondrial Ca 2+ peaks was observed upon Mfn2 siRNA knockdown, as compared to NC (Fig. 3A) . These results show that mitochondrial Ca 2+ uptake, upon ER Ca 2+ release, can be modulated by the proximity of the two organelles. In addition, mitochondrial Ca 2+ uptake may also depend on the amount of Ca 2+ released from the ER facing mitochondria and on the levels of MCU. To investigate whether the two latter features contributed to the observed phenomenon, we first measured the cytosolic Ca 2+ peaks obtained upon stimulation with ATP and CCH in cells expressing cytosolic aequorin (Fig. 3B) . Secondly, we investigated mitochondrial Ca 2+ uptake in permeabilized cells exposed to fixed amounts of Ca 2+ ( Fig. S2A and B) . No significant differences were detected between NC-and Mfn2 siRNA-treated cells using these approaches ( Fig. 3B and C, Fig. S2A and B) . Furthermore, the protein levels of IP3R3 (mediating Ca 2+ release from the ER) and VDAC1 and MCU (mediating mitochondrial Ca 2+ uptake) were not affected by Mfn2 knockdown (Fig. 3D) . Cytochrome c oxidase (COX IV) was used as a mitochondrial marker. These data are in accordance with our TEM results and show that Mfn2 knockdown in HEK293 APPswe cells results in an increased ER-mitochondria contact.
Knockdown of Mfn2 leads to decreased Ab production via impairment of c-secretase maturation and activity
Having established a cell model with increased ER-mitochondria contact, we next tested our hypothesis that the modulation of ER-mitochondria contact influences APP processing and Ab production. Levels of intracellular and secreted Ab were detected by a commercial ELISA. Interestingly, the levels of both intracellular and secreted Ab 40 and Ab 42 were decreased around 40% in cells treated with Mfn2 siRNA, as compared to NC siRNA (Fig. 4) .
To elucidate whether the decrease in Ab levels was as a result of impaired APP maturation, altered APP processing or increased Ab degradation, we performed the following experiments. First, Western blot analysis revealed that the expression levels of total APP as well as of mature and immature APP were similar in Mfn2 siRNA-and NC siRNA-treated cells (Fig. 5A) . Amyloid-b precursor protein is glycosylated in ER and Golgi and fully matured when reaching the plasma membrane [41] . The data show that this process is not affected by Mfn2 knockdown.
Second, we detected BACE1 and c-secretase protein expression and measured c-secretase activity. Western blot studies revealed that BACE1 levels were not changed in cells treated with Mfn2 siRNA. Interestingly, levels of PS1 and PS2 C-and N-terminal fragments (PS1/2-CTFs and PS1/2-NTFs) were significantly reduced (Fig. 5A) after Mfn2 knockdown. Moreover, levels of PEN-2 and immature NCT increased, while APH-1 levels were unaltered in Mfn2 siRNA-treated cells (Fig. 5A ). c-Secretase activity was measured in an assay detecting AICD formation from membrane fractions incubated overnight in the absence or presence of the c-secretase inhibitor L-685,458. Decreased AICD production was detected in cells treated with Mfn2 siRNA as compared to NC siRNA (Fig. 5B, Fig. S3C ). Levels of C83 and C99 were unaltered (Fig. 5B, Fig. S3A and B) . In this assay, membrane fractions isolated from siRNA-treated cells were incubated in a 1% CHAPSO buffer for 16 hrs. The amounts of AICD, formed from the c-secretase substrates C83/C99, were subsequently detected by Western blot. Our results show that sufficient amounts of C83/C99 were present in the membrane fraction, and thus decreased AICD levels reflect lower c-secretase activity in Mfn2 siRNA-treated cells as compared to NC siRNA-treated cells. Altogether these data show that increased ER-mitochondria contact negatively affects c-secretase complex maturation and activity.
Finally, we investigated both activity and protein levels of neprilysin. Neprilysin is a membrane-bound zinc-dependent metalloprotease that degrades different peptides, including Ab. Neprilysin has been shown to be one of the major Ab-degrading enzymes [42] . Neprilysin activity and protein expression were similar in Mfn2 siRNA-treated cells as compared to NC siRNA-treated cells (Fig. 5C ). These data show that decreased Ab concentrations in Mfn2 siRNA-treated cells were not because of the increased peptide degradation by neprilysin.
Discussion
In the recent years altered functions of MAM and ER-mitochondria communication have been described in disorders such as AD, cardiovascular disease and obesity [14, 24, 43, 44] . In this study we show that Mfn2 knockdown increases ER-mitochondria juxtaposition, decreases levels of intracellular and secreted Ab and impairs c-secretase activity. The pathway for Ab generation is well-established, however the intracellular regulation of this process is not fully understood [29] [30] [31] [32] . Several proteins have been shown to modulate c-secretase activity and thus Ab production (e.g. VDAC1, c-secretase-activating protein, reticulon protein family). These proteins present different functions and subcellular localizations within the cell [45] [46] [47] [48] . Still, the exact mechanisms of how these proteins modulate c-secretase activity remain to be elucidated. Here, we have tested an alternative hypothesis proposing that modulation of ER-mitochondria contacts affects Ab generation.
Mfn2 has been described to have an essential role in the tethering of ER and mitochondria [6] [7] [8] [9] . As a result of its specific location and function at ER-mitochondria contacts, the ablation or reduction of this protein has been used for the modulation of ER-mitochondria contacts [6] [7] [8] [9] 15] . However, the role of Mfn2 as a tethering protein between ER and mitochondria has recently been questioned by us and others [7] [8] [9] . In the present study, Ca 2+ measurements and TEManalysis show that the knockdown of Mfn2 results in increased coupling between ER and mitochondria. This is in accordance with recent publications proposing that Mfn2 works as an ER-mitochondria tetheering antagonist [7] [8] [9] .
Mfn2 siRNA treatment also resulted in dilated mitochondrial cristae, supporting the importance of Mfn2 in mitochondrial morphology. Mitofusin-1 and -2 seem to have partially redundant physiological functions, where Mfn1 can compensate for Mfn2 reduction and vice versa [49, 50] . Accordingly, our data show that Mfn1 protein levels were slightly increased in cells treated with Mfn2 siRNA. Thus, Mfn1 could compensate for Mfn2 knockdown in terms of energy production and cell viability but not in terms of mitochondrial morphology.
In our model, the knockdown of Mfn2 siRNA and the increase in ER-mitochondria Ca 2+ transfer did not cause mitochondrial failure and cell death (at least not within the treatment period). Ca 2+ is crucial for cell homoeostasis. Upon certain stimuli the levels of Ca 2+ in the cytosol can rise. Mitochondria have the ability to rapidly buffer such increased cytosolic Ca 2+ by accumulating Ca 2+ in the matrix. This buffering tunes overall Ca 2+ signalling within the cell [51] . Moreover, changes in mitochondrial Ca 2+ levels can have an impact in the metabolic regulation of Ca 2+ -activated matrix dehydrogenases, thus modulating ATP production [51] [52] [53] [54] [55] . In fact, small Ca 2+ changes within mitochondria (0.1-10 lM) can lead to major changes inside the cell [51] [52] [53] [54] [55] . Disruption of Ca 2+ homoeostasis as a result of the long or intense treatments/ stimuli can lead to cell death (e.g. overload of mitochondrial Ca 2+ triggers apoptosis). Several studies have shown that PS mutations lead to changes in Ca 2+ homoeostasis by increasing cytosolic Ca 2+ [56] [57] [58] . It has also been shown that PS1 and PS2 have a c-secretase-independent role in the regulation of calcium homoeostasis and tethering between ER and mitochondria [13, 56] . Moreover, it has been shown that increased cytosolic Ca 2+ leads to decreased APP levels and subsequently decreased Ab production [59] . However, in our study, Mfn2 knockdown did not result in an alteration in the bulk cytosolic Ca demonstrating a straitened coupling between the two organelles) suggests that the observed decreased c-secretase activity and Ab levels were not caused by alterations in cytosolic Ca 2+ . However, further investigations need to be done to understand the mechanism by which altered ER-mitochondria contact and Ca 2+ transfer affect c-secretase maturation, assembly and activity.
Here, quantitative measurements of intra-and extracellular Ab 40 and Ab 42 in cells treated with Mfn2 siRNA showed that increased ERmitochondria contact decreased Ab levels. Possible mechanisms behind this decrease in Ab generation include: (i) decreased levels or impaired maturation of APP, (ii) decreased expression of BACE1 and/ or c-secretase proteins and/or activities, (iii) increased degradation of Ab. Firstly, our data show that APP protein levels were unaltered and that mature APP was available for BACE1 and c-secretase cleavage in cells treated with Mfn2 siRNA. Secondly, BACE1 protein levels were unaltered and degradation of Ab was not enhanced as measured by a neprilysin activity assay. Thirdly, alterations in the expression and maturation of c-secretase complex components were identified along with decreased c-secretase activity. The c-secretase complex assembles and matures in the secretory pathway. Nicastrin and APH-1 first form a scaffolding complex to which PS1 (or PS2) binds. Presenilin enhancer 2 stabilizes this complex and activates endoproteolysis of PS1 (or PS2) [29] [30] [31] [32] . Moreover, it has been shown that APP and active c-secretase complexes are enriched in lipid rafts [24, 33, 60, 61] of the plasma membrane, endosomes, autophagosomes, synaptosomes and MAM [14] [15] [16] . Lipid rafts are thus important sites for Ab production [34, 61] . Here we detected both mature and immature NCT in Mfn2 siRNA-treated cells, while cells treated with control siRNA only expressed mature NCT. APH-1 levels were not affected by Mfn2 knockdown. The presence of immature NCT suggests that less scaffolding complexes are available for binding of PS1 (or PS2) and PEN2 under these conditions. In addition, we show that the protein levels of PS1 and PS2 (NTFs and CTFs) were decreased when Mfn2 is knocked down. c-Secretase complexes containing endoproteolysed PS1 are mainly responsible for the generation of Ab, while c-secretase complexes containing PS2 are less active in cleaving C99 [29] [30] [31] [32] . PEN-2 protein levels were increased in Mfn2 siRNAtreated cells suggesting that PEN2 was not a limiting factor for endoproteolysis of PS. Importantly, decreased c-secretase activity, as measured by AICD formation, was detected. Thus, the presence of immature NCT and low levels of PS1-NTFs and CTFs are likely the cause of low c-secretase activity in cells treated with Mfn2 siRNA. These results are in accordance with previous studies showing that mouse embryonic fibroblast cells lacking Mfn2 (MEF Mfn2-KO) present a decreased activity of c-secretase [14] .
To elucidate the exact relation between ER-mitochondria contacts and c-secretase activity more experiments need to be done. At present we can only speculate about the mechanisms behind the impairment of c-secretase complex assembly and activity. Changes in phospholipid and cholesterol metabolism and calcium homoeostasis have been linked to AD [14, 16, 62, 63] . As previously mentioned, APP and active c-secretase complexes are enriched in lipid rafts [24, 33, 60, 61] . Mitochondria-associated ER membranes are crucial for biosynthesis of different phospholipids and cholesterol. Therefore, modulation of ER-mitochondria contact may alter MAM function and phospholipid/ cholesterol synthesis resulting in altered lipid raft composition and c-secretase activity [14, 32, 33, 63] . Furthermore, if we consider the importance of the phospholipids produced at MAM for vesicle formation, modulation of ER-mitochondria contacts could lead to altered transport/localization of c-secretase complexes inside the cell.
In summary, we show that c-secretase complex maturation and activity is affected by increased ER-mitochondria contact leading to decreased Ab levels. More experiments are required to determine if ER-mitochondria contacts can be modulated to specifically target cleavage of APP without affecting other c-secretase substrates. Even though ablation of Mfn2 is not a realistic treatment strategy, because of the importance of this protein for long-term mitochondrial stability, our data show that acute modulation of ER-mitochondria contact affects c-secretase assembly and function. This finding opens up for new strategies to modulate c-secretase activity, apart from c-secretase inhibitors and modulators. Altogether, the present data reinforce other studies suggesting that modulation of MAM functions and ERmitochondria communication may hold potential as novel drug targets for future AD therapy. Data S1 Material and methods.
